Share Price and Basic Stock Data
Last Updated: April 4, 2025, 11:13 am
PEG Ratio | 2.15 |
---|
Competitors of Nucleus Software Exports Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
IDream Film Infrastructure Company Ltd | 1.79 Cr. | 120 | 120/89.3 | 295 | 0.00 % | % | % | 10.0 | |
I Power Solutions India Ltd | 7.42 Cr. | 16.7 | 16.7/10.8 | 8.99 | 0.00 % | 3.67 % | 3.83 % | 10.0 | |
Hypersoft Technologies Ltd | 8.64 Cr. | 20.3 | 20.3/7.55 | 5.13 | 0.00 % | 8.57 % | 10.7 % | 10.0 | |
Sonata Software Ltd | 9,185 Cr. | 328 | 770/326 | 21.5 | 53.5 | 2.44 % | 35.5 % | 30.3 % | 1.00 |
Softtech Engineers Ltd | 503 Cr. | 364 | 612/277 | 212 | 92.5 | 0.00 % | 6.40 % | 2.79 % | 10.0 |
Industry Average | 147,492.54 Cr | 827.94 | 42.20 | 136.08 | 0.75% | 21.15% | 17.71% | 7.00 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 122 | 153 | 129 | 130 | 169 | 206 | 207 | 205 | 204 | 210 | 195 | 202 | 206 |
Expenses | 116 | 128 | 114 | 119 | 121 | 123 | 144 | 153 | 156 | 152 | 166 | 170 | 172 |
Operating Profit | 6 | 25 | 15 | 11 | 48 | 83 | 63 | 52 | 48 | 58 | 29 | 32 | 33 |
OPM % | 5% | 16% | 11% | 9% | 28% | 40% | 30% | 25% | 23% | 28% | 15% | 16% | 16% |
Other Income | 8 | 6 | 6 | 9 | 9 | 10 | 13 | 12 | 12 | 14 | 15 | 19 | 16 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Profit before tax | 9 | 26 | 16 | 15 | 52 | 89 | 72 | 60 | 56 | 68 | 40 | 47 | 45 |
Tax % | 15% | 30% | 31% | 26% | 26% | 24% | 25% | 26% | 26% | 24% | 24% | 29% | 22% |
Net Profit | 8 | 18 | 11 | 11 | 38 | 68 | 54 | 45 | 41 | 52 | 30 | 33 | 35 |
EPS in Rs | 2.77 | 6.83 | 4.02 | 4.12 | 14.32 | 25.27 | 20.01 | 16.65 | 15.43 | 19.47 | 11.28 | 12.35 | 13.06 |
Last Updated: February 28, 2025, 6:05 pm
Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹206.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Sep 2024) to ₹206.00 Cr., marking an increase of 4.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹172.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 170.00 Cr. (Sep 2024) to ₹172.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹33.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Sep 2024) to ₹33.00 Cr., marking an increase of 1.00 Cr..
- For OPM %, as of Dec 2024, the value is 16.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 16.00%.
- For Other Income, as of Dec 2024, the value is ₹16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to ₹16.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹4.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 4.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹45.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Sep 2024) to ₹45.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Dec 2024, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Sep 2024) to 22.00%, marking a decrease of 7.00%.
- For Net Profit, as of Dec 2024, the value is ₹35.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Sep 2024) to ₹35.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 13.06. The value appears strong and on an upward trend. It has increased from 12.35 (Sep 2024) to 13.06, marking an increase of 0.71.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 3:20 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 294 | 346 | 353 | 349 | 372 | 412 | 484 | 521 | 514 | 497 | 634 | 826 | 814 |
Expenses | 247 | 278 | 287 | 318 | 319 | 353 | 405 | 427 | 384 | 460 | 478 | 606 | 661 |
Operating Profit | 46 | 68 | 66 | 31 | 54 | 59 | 79 | 94 | 129 | 37 | 157 | 220 | 152 |
OPM % | 16% | 20% | 19% | 9% | 14% | 14% | 16% | 18% | 25% | 7% | 25% | 27% | 19% |
Other Income | 20 | 24 | 33 | 26 | 32 | 29 | 27 | 37 | 39 | 35 | 34 | 51 | 64 |
Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 6 | 8 | 12 | 12 | 11 | 7 | 10 | 14 | 14 | 15 | 19 | 15 | 15 |
Profit before tax | 60 | 83 | 87 | 44 | 74 | 80 | 96 | 117 | 154 | 56 | 171 | 256 | 200 |
Tax % | 25% | 23% | 25% | 26% | 11% | 22% | 23% | 24% | 23% | 26% | 25% | 25% | |
Net Profit | 45 | 64 | 65 | 32 | 66 | 63 | 75 | 89 | 118 | 41 | 128 | 192 | 150 |
EPS in Rs | 13.95 | 19.87 | 19.98 | 10.03 | 20.43 | 21.54 | 25.67 | 30.64 | 40.62 | 15.28 | 47.73 | 71.56 | 56.16 |
Dividend Payout % | 22% | 30% | 25% | 50% | 24% | 37% | 35% | 29% | 22% | 46% | 21% | 17% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 42.22% | 1.56% | -50.77% | 106.25% | -4.55% | 19.05% | 18.67% | 32.58% | -65.25% | 212.20% | 50.00% |
Change in YoY Net Profit Growth (%) | 0.00% | -40.66% | -52.33% | 157.02% | -110.80% | 23.59% | -0.38% | 13.92% | -97.84% | 277.45% | -162.20% |
Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 11% |
3 Years: | 17% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 18% |
3 Years: | 18% |
TTM: | -27% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 35% |
3 Years: | 22% |
1 Year: | -42% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 17% |
3 Years: | 17% |
Last Year: | 24% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 7:57 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 32 | 32 | 32 | 32 | 32 | 29 | 29 | 29 | 29 | 27 | 27 | 27 | 26 |
Reserves | 318 | 365 | 406 | 425 | 503 | 432 | 480 | 532 | 643 | 467 | 584 | 751 | 690 |
Borrowings | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 6 | 2 | 6 | 5 | 3 |
Other Liabilities | 109 | 116 | 118 | 123 | 131 | 184 | 177 | 196 | 206 | 241 | 257 | 332 | 428 |
Total Liabilities | 459 | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,147 |
Fixed Assets | 51 | 61 | 58 | 54 | 48 | 48 | 47 | 57 | 50 | 59 | 50 | 59 | 57 |
CWIP | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
Investments | 155 | 224 | 170 | 245 | 441 | 387 | 424 | 475 | 635 | 480 | 525 | 649 | 656 |
Other Assets | 253 | 228 | 328 | 281 | 176 | 210 | 214 | 231 | 200 | 198 | 298 | 406 | 428 |
Total Assets | 459 | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,147 |
Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2024) to ₹26.00 Cr., marking a decrease of 1.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹690.00 Cr.. The value appears to be declining and may need further review. It has decreased from 751.00 Cr. (Mar 2024) to ₹690.00 Cr., marking a decrease of 61.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹3.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to ₹3.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹428.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 332.00 Cr. (Mar 2024) to ₹428.00 Cr., marking an increase of 96.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹1,147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,114.00 Cr. (Mar 2024) to ₹1,147.00 Cr., marking an increase of 33.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2024) to ₹57.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to ₹6.00 Cr., marking an increase of 5.00 Cr..
- For Investments, as of Sep 2024, the value is ₹656.00 Cr.. The value appears strong and on an upward trend. It has increased from 649.00 Cr. (Mar 2024) to ₹656.00 Cr., marking an increase of 7.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹428.00 Cr.. The value appears strong and on an upward trend. It has increased from 406.00 Cr. (Mar 2024) to ₹428.00 Cr., marking an increase of 22.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹1,147.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,114.00 Cr. (Mar 2024) to ₹1,147.00 Cr., marking an increase of 33.00 Cr..
Notably, the Reserves (690.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 46.00 | 68.00 | 66.00 | 30.00 | 54.00 | 59.00 | 79.00 | 88.00 | 123.00 | 35.00 | 151.00 | 215.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 87 | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 87 | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 |
Working Capital Days | 19 | -5 | 14 | 9 | -43 | -66 | -51 | -51 | -58 | -75 | -14 | -36 |
ROCE % | 18% | 21% | 19% | 10% | 15% | 16% | 19% | 21% | 22% | 6% | 27% | 32% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
WhiteOak Capital Flexi Cap Fund | 113,333 | 0.63 | 16.66 | 4,324 | 2025-04-02 | 2521.02% |
ICICI Prudential Innovation Fund | 65,999 | 0.3 | 9.7 | 4,324 | 2025-04-02 | 1426.34% |
WhiteOak Capital Mid Cap Fund | 45,586 | 0.51 | 6.7 | 4,324 | 2025-04-02 | 954.26% |
Quant Teck Fund | 38,000 | 2.75 | 5.58 | 4,324 | 2025-04-02 | 778.82% |
WhiteOak Capital Multi Cap Fund | 25,166 | 0.71 | 3.7 | 4,324 | 2025-04-02 | 482.01% |
WhiteOak Capital Large Cap Fund | 11,472 | 0.46 | 1.69 | 4,324 | 2025-04-02 | 165.31% |
WhiteOak Capital Balanced Advantage Fund | 8,909 | 0.18 | 1.31 | 4,324 | 2025-04-02 | 106.04% |
ICICI Prudential Technology Fund | 6,651 | 0.01 | 0.98 | 4,324 | 2025-04-02 | 53.82% |
WhiteOak Capital ELSS Tax Saver Fund | 4,324 | 0.58 | 0.64 | 4,324 | 2025-04-02 | 0% |
WhiteOak Capital Multi Asset Allocation Fund | 1,716 | 0.1 | 0.25 | 4,324 | 2025-04-02 | -60.31% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 71.56 | 47.73 | 14.28 | 40.62 | 30.64 |
Diluted EPS (Rs.) | 71.56 | 47.73 | 14.28 | 40.62 | 30.64 |
Cash EPS (Rs.) | 77.01 | 54.73 | 21.03 | 45.39 | 35.31 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 290.41 | 228.11 | 184.38 | 231.41 | 193.14 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 290.41 | 228.11 | 184.38 | 231.41 | 193.14 |
Revenue From Operations / Share (Rs.) | 308.72 | 237.00 | 185.73 | 176.84 | 179.35 |
PBDIT / Share (Rs.) | 101.34 | 71.28 | 26.78 | 58.16 | 45.27 |
PBIT / Share (Rs.) | 95.91 | 64.29 | 21.03 | 53.38 | 40.60 |
PBT / Share (Rs.) | 95.55 | 63.91 | 20.73 | 52.96 | 40.21 |
Net Profit / Share (Rs.) | 71.57 | 47.74 | 15.28 | 40.62 | 30.64 |
NP After MI And SOA / Share (Rs.) | 71.57 | 47.74 | 15.28 | 40.62 | 30.64 |
PBDIT Margin (%) | 32.82 | 30.07 | 14.41 | 32.88 | 25.23 |
PBIT Margin (%) | 31.06 | 27.12 | 11.32 | 30.18 | 22.63 |
PBT Margin (%) | 30.95 | 26.96 | 11.16 | 29.95 | 22.42 |
Net Profit Margin (%) | 23.18 | 20.14 | 8.22 | 22.96 | 17.08 |
NP After MI And SOA Margin (%) | 23.18 | 20.14 | 8.22 | 22.96 | 17.08 |
Return on Networth / Equity (%) | 24.64 | 20.92 | 8.28 | 17.55 | 15.86 |
Return on Capital Employeed (%) | 31.36 | 26.84 | 10.84 | 22.57 | 20.53 |
Return On Assets (%) | 17.19 | 14.61 | 5.55 | 13.33 | 11.66 |
Asset Turnover Ratio (%) | 0.83 | 0.74 | 0.56 | 0.56 | 0.62 |
Current Ratio (X) | 2.07 | 2.07 | 2.09 | 3.11 | 2.36 |
Quick Ratio (X) | 2.07 | 2.07 | 2.09 | 3.11 | 2.36 |
Dividend Payout Ratio (NP) (%) | 13.97 | 14.66 | 42.58 | 7.38 | 29.37 |
Dividend Payout Ratio (CP) (%) | 12.98 | 12.79 | 30.94 | 6.60 | 25.49 |
Earning Retention Ratio (%) | 86.03 | 85.34 | 57.42 | 92.62 | 70.63 |
Cash Earning Retention Ratio (%) | 87.02 | 87.21 | 69.06 | 93.40 | 74.51 |
Interest Coverage Ratio (X) | 285.58 | 187.09 | 88.51 | 138.44 | 117.37 |
Interest Coverage Ratio (Post Tax) (X) | 202.68 | 126.28 | 51.51 | 97.68 | 80.46 |
Enterprise Value (Cr.) | 3091.48 | 1658.15 | 1054.42 | 1353.67 | 425.81 |
EV / Net Operating Revenue (X) | 3.74 | 2.61 | 2.12 | 2.64 | 0.81 |
EV / EBITDA (X) | 11.40 | 8.69 | 14.71 | 8.01 | 3.24 |
MarketCap / Net Operating Revenue (X) | 3.83 | 2.69 | 2.23 | 2.72 | 0.98 |
Retention Ratios (%) | 86.02 | 85.33 | 57.41 | 92.61 | 70.62 |
Price / BV (X) | 4.07 | 2.80 | 2.25 | 2.08 | 0.91 |
Price / Net Operating Revenue (X) | 3.83 | 2.69 | 2.23 | 2.72 | 0.98 |
EarningsYield | 0.06 | 0.07 | 0.03 | 0.08 | 0.17 |
After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 71.56. This value is within the healthy range. It has increased from 47.73 (Mar 23) to 71.56, marking an increase of 23.83.
- For Diluted EPS (Rs.), as of Mar 24, the value is 71.56. This value is within the healthy range. It has increased from 47.73 (Mar 23) to 71.56, marking an increase of 23.83.
- For Cash EPS (Rs.), as of Mar 24, the value is 77.01. This value is within the healthy range. It has increased from 54.73 (Mar 23) to 77.01, marking an increase of 22.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 290.41. It has increased from 228.11 (Mar 23) to 290.41, marking an increase of 62.30.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 290.41. It has increased from 228.11 (Mar 23) to 290.41, marking an increase of 62.30.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 308.72. It has increased from 237.00 (Mar 23) to 308.72, marking an increase of 71.72.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 101.34. This value is within the healthy range. It has increased from 71.28 (Mar 23) to 101.34, marking an increase of 30.06.
- For PBIT / Share (Rs.), as of Mar 24, the value is 95.91. This value is within the healthy range. It has increased from 64.29 (Mar 23) to 95.91, marking an increase of 31.62.
- For PBT / Share (Rs.), as of Mar 24, the value is 95.55. This value is within the healthy range. It has increased from 63.91 (Mar 23) to 95.55, marking an increase of 31.64.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 71.57. This value is within the healthy range. It has increased from 47.74 (Mar 23) to 71.57, marking an increase of 23.83.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 71.57. This value is within the healthy range. It has increased from 47.74 (Mar 23) to 71.57, marking an increase of 23.83.
- For PBDIT Margin (%), as of Mar 24, the value is 32.82. This value is within the healthy range. It has increased from 30.07 (Mar 23) to 32.82, marking an increase of 2.75.
- For PBIT Margin (%), as of Mar 24, the value is 31.06. This value exceeds the healthy maximum of 20. It has increased from 27.12 (Mar 23) to 31.06, marking an increase of 3.94.
- For PBT Margin (%), as of Mar 24, the value is 30.95. This value is within the healthy range. It has increased from 26.96 (Mar 23) to 30.95, marking an increase of 3.99.
- For Net Profit Margin (%), as of Mar 24, the value is 23.18. This value exceeds the healthy maximum of 10. It has increased from 20.14 (Mar 23) to 23.18, marking an increase of 3.04.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 23.18. This value exceeds the healthy maximum of 20. It has increased from 20.14 (Mar 23) to 23.18, marking an increase of 3.04.
- For Return on Networth / Equity (%), as of Mar 24, the value is 24.64. This value is within the healthy range. It has increased from 20.92 (Mar 23) to 24.64, marking an increase of 3.72.
- For Return on Capital Employeed (%), as of Mar 24, the value is 31.36. This value is within the healthy range. It has increased from 26.84 (Mar 23) to 31.36, marking an increase of 4.52.
- For Return On Assets (%), as of Mar 24, the value is 17.19. This value is within the healthy range. It has increased from 14.61 (Mar 23) to 17.19, marking an increase of 2.58.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has increased from 0.74 (Mar 23) to 0.83, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 24, the value is 2.07. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.07.
- For Quick Ratio (X), as of Mar 24, the value is 2.07. This value exceeds the healthy maximum of 2. There is no change compared to the previous period (Mar 23) which recorded 2.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 13.97. This value is below the healthy minimum of 20. It has decreased from 14.66 (Mar 23) to 13.97, marking a decrease of 0.69.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.98. This value is below the healthy minimum of 20. It has increased from 12.79 (Mar 23) to 12.98, marking an increase of 0.19.
- For Earning Retention Ratio (%), as of Mar 24, the value is 86.03. This value exceeds the healthy maximum of 70. It has increased from 85.34 (Mar 23) to 86.03, marking an increase of 0.69.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.02. This value exceeds the healthy maximum of 70. It has decreased from 87.21 (Mar 23) to 87.02, marking a decrease of 0.19.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 285.58. This value is within the healthy range. It has increased from 187.09 (Mar 23) to 285.58, marking an increase of 98.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 202.68. This value is within the healthy range. It has increased from 126.28 (Mar 23) to 202.68, marking an increase of 76.40.
- For Enterprise Value (Cr.), as of Mar 24, the value is 3,091.48. It has increased from 1,658.15 (Mar 23) to 3,091.48, marking an increase of 1,433.33.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 23) to 3.74, marking an increase of 1.13.
- For EV / EBITDA (X), as of Mar 24, the value is 11.40. This value is within the healthy range. It has increased from 8.69 (Mar 23) to 11.40, marking an increase of 2.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 2.69 (Mar 23) to 3.83, marking an increase of 1.14.
- For Retention Ratios (%), as of Mar 24, the value is 86.02. This value exceeds the healthy maximum of 70. It has increased from 85.33 (Mar 23) to 86.02, marking an increase of 0.69.
- For Price / BV (X), as of Mar 24, the value is 4.07. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 23) to 4.07, marking an increase of 1.27.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.83. This value exceeds the healthy maximum of 3. It has increased from 2.69 (Mar 23) to 3.83, marking an increase of 1.14.
- For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.06, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
- Net Profit Margin: 23.18%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 31.36% (Industry Average ROCE: 20.04%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.64% (Industry Average ROE: 15.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 202.68
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.4 (Industry average Stock P/E: 31.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.18%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
IT Consulting & Software | 33-35, Thyagraj Nagar Market, New Delhi Delhi 110003 | investorrelations@nucleussoftware.com http://www.nucleussoftware.com |
Management | |
---|---|
Name | Position Held |
Mr. S M Acharya | Chairman(NonExe.&Ind.Director) |
Mr. Vishnu R Dusad | Managing Director |
Mr. Anurag Mantri | Executive Director & CFO |
Mr. Parag Bhise | Executive Director & CEO |
Mr. Ravi Pratap Singh | Executive Director |
Dr. Ritika Dusad | Executive Director |
Mr. Prithvi Haldea | Ind. Non-Executive Director |
Mrs. Elaine Mathias | Ind. Non-Executive Director |
Prof. Trilochan Sastry | Ind. Non-Executive Director |
Ms. Yasmin Javeri Krishan | Ind. Non-Executive Director |
Mr. P C Kandpal | Ind. Non-Executive Director |
Mr. Shekar Viswanathan | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Nucleus Software Exports Ltd?
Nucleus Software Exports Ltd's intrinsic value (as of 04 April 2025) is ₹752.38 — 6.77% lower the current market price of ₹807.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,161 Cr. market cap, FY2025-2026 high/low of ₹1,645/791, reserves of 690 Cr, and liabilities of 1,147 Cr.
What is the Market Cap of Nucleus Software Exports Ltd?
The Market Cap of Nucleus Software Exports Ltd is 2,161 Cr..
What is the current Stock Price of Nucleus Software Exports Ltd as on 04 April 2025?
The current stock price of Nucleus Software Exports Ltd as on 04 April 2025 is 807.
What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is ₹1,645/791.
What is the Stock P/E of Nucleus Software Exports Ltd?
The Stock P/E of Nucleus Software Exports Ltd is 14.4.
What is the Book Value of Nucleus Software Exports Ltd?
The Book Value of Nucleus Software Exports Ltd is 268.
What is the Dividend Yield of Nucleus Software Exports Ltd?
The Dividend Yield of Nucleus Software Exports Ltd is 1.54 %.
What is the ROCE of Nucleus Software Exports Ltd?
The ROCE of Nucleus Software Exports Ltd is 32.0 %.
What is the ROE of Nucleus Software Exports Ltd?
The ROE of Nucleus Software Exports Ltd is 24.0 %.
What is the Face Value of Nucleus Software Exports Ltd?
The Face Value of Nucleus Software Exports Ltd is 10.0.